{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:23:38Z","timestamp":1790969018166,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04213-y","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:02:01Z","timestamp":1709866921000},"page":"1351-1362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison between pelvic MRI, CT, and PET\/CT in baseline staging and radiation planning of anal squamous cell carcinoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Natally","family":"Horvat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetri Sudar","family":"Jayaprakasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gangai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Romesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Golia Pernicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinela","family":"Capanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-0730","authenticated-orcid":false,"given":"Marc J.","family":"Gollub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"3","key":"4213_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. doi: https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"4213_CR2","unstructured":"National Cancer Institute Surveillance E, and End Results Program (SEER): Cancer Stat Facts: Anal Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/anus.html (2022). Accessed April 12, 2022."},{"issue":"8","key":"4213_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jnci\/djz219","volume":"112","author":"AA Deshmukh","year":"2020","unstructured":"Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, et al. Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015. J Natl Cancer Inst. 2020;112(8):829-38. doi: https:\/\/doi.org\/10.1093\/jnci\/djz219.","journal-title":"J Natl Cancer Inst."},{"issue":"10","key":"4213_CR4","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::aid-cncr2820511012>3.0.co;2-l","volume":"51","author":"ND Nigro","year":"1983","unstructured":"Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983;51(10):1826-9. doi: https:\/\/doi.org\/10.1002\/1097-0142(19830515)51:10<1826::aid-cncr2820511012>3.0.co;2-l.","journal-title":"Cancer."},{"issue":"4","key":"4213_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.6004\/jnccn.2012.0046","volume":"10","author":"AB Benson 3rd","year":"2012","unstructured":"Benson AB, 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, et al. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10(4):449-54. doi: https:\/\/doi.org\/10.6004\/jnccn.2012.0046.","journal-title":"J Natl Compr Canc Netw."},{"issue":"10","key":"4213_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","volume":"40","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40(10):1165-76. doi: https:\/\/doi.org\/10.1016\/j.ejso.2014.07.030.","journal-title":"Eur J Surg Oncol."},{"issue":"Suppl 1","key":"4213_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/codi.13709","volume":"19","author":"I Geh","year":"2017","unstructured":"Geh I, Gollins S, Renehan A, Scholefield J, Goh V, Prezzi D, et al. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017)\u2014Anal Cancer. Colorectal Dis. 2017;19 Suppl 1:82-97. doi: https:\/\/doi.org\/10.1111\/codi.13709.","journal-title":"Colorectal Dis."},{"issue":"8","key":"4213_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.dld.2017.05.011","volume":"49","author":"L Moureau-Zabotto","year":"2017","unstructured":"Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, et al. Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP). Dig Liver Dis. 2017;49(8):831-40. doi: https:\/\/doi.org\/10.1016\/j.dld.2017.05.011.","journal-title":"Dig Liver Dis."},{"issue":"7","key":"4213_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/DCR.0000000000001114","volume":"61","author":"DB Stewart","year":"2018","unstructured":"Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum. 2018;61(7):755-74. doi: https:\/\/doi.org\/10.1097\/DCR.0000000000001114.","journal-title":"Dis Colon Rectum."},{"issue":"9","key":"4213_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","volume":"32","author":"S Rao","year":"2021","unstructured":"Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE, et al. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606). Ann Oncol. 2021;32(9):1087-100. doi: https:\/\/doi.org\/10.1016\/j.annonc.2021.06.015.","journal-title":"Ann Oncol."},{"key":"4213_CR11","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Anal Carcinoma. Version 2.2022."},{"issue":"24","key":"4213_CR12","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1200\/JCO.21.02566","volume":"40","author":"C Eng","year":"2022","unstructured":"Eng C, Ciombor KK, Cho M, Dorth JA, Rajdev LN, Horowitz DP, et al. Anal Cancer: Emerging Standards in a Rare Disease. J Clin Oncol. 2022;40(24):2774-88. doi: https:\/\/doi.org\/10.1200\/JCO.21.02566.","journal-title":"J Clin Oncol."},{"issue":"9","key":"4213_CR13","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.3390\/jcm9092715","volume":"9","author":"R Manafi-Farid","year":"2020","unstructured":"Manafi-Farid R, Kupferthaler A, Wundsam H, Gruber G, Vali R, Venhoda C, et al. Additional Value of 2-[(18)F]FDG PET\/CT Comparing to MRI in Treatment Approach of Anal Cancer Patients. J Clin Med. 2020;9(9):2715. doi: https:\/\/doi.org\/10.3390\/jcm9092715.","journal-title":"J Clin Med."},{"key":"4213_CR14","unstructured":"American Cancer Society: Anal Cancer Stages. https:\/\/www.cancer.org\/cancer\/types\/anal-cancer\/detection-diagnosis-staging\/staging.html (2023). Accessed 13 Sept 2023."},{"issue":"2","key":"4213_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/bjs\/znaa009","volume":"108","author":"DP Schaap","year":"2021","unstructured":"Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg. 2021;108(2):205-13. doi: https:\/\/doi.org\/10.1093\/bjs\/znaa009.","journal-title":"Br J Surg."},{"issue":"4","key":"4213_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","volume":"28","author":"RGH Beets-Tan","year":"2018","unstructured":"Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology. 2018;28(4):1465-75. doi: https:\/\/doi.org\/10.1007\/s00330-017-5026-2.","journal-title":"Eur Radiol."},{"issue":"5","key":"4213_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.semnuclmed.2021.04.001","volume":"51","author":"VS Jayaprakasam","year":"2021","unstructured":"Jayaprakasam VS, Paroder V, Schoder H. Variants and Pitfalls in PET\/CT Imaging of Gastrointestinal Cancers. Semin Nucl Med. 2021;51(5):485-501. doi: https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.001.","journal-title":"Semin Nucl Med."},{"issue":"1","key":"4213_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27-33. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2012.09.023.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"4213_CR19","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.esmoop.2021.100180","volume":"6","author":"C Astaras","year":"2021","unstructured":"Astaras C, Bornand A, Koessler T. Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations. ESMO Open. 2021;6(4):100180. doi: https:\/\/doi.org\/10.1016\/j.esmoop.2021.100180.","journal-title":"ESMO Open."},{"issue":"1","key":"4213_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijrobp.2011.10.048","volume":"84","author":"M Mistrangelo","year":"2012","unstructured":"Mistrangelo M, Pelosi E, Bello M, Ricardi U, Milanesi E, Cassoni P, et al. Role of positron emission tomography-computed tomography in the management of anal cancer. Int J Radiat Oncol Biol Phys. 2012;84(1):66-72. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.048.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"4213_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1245\/s10434-010-1275-x","volume":"18","author":"P De Nardi","year":"2011","unstructured":"De Nardi P, Carvello M, Canevari C, Passoni P, Staudacher C. Sentinel node biopsy in squamous-cell carcinoma of the anal canal. Ann Surg Oncol. 2011;18(2):365-70. doi: https:\/\/doi.org\/10.1245\/s10434-010-1275-x.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"4213_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijrobp.2009.04.020","volume":"77","author":"M Mistrangelo","year":"2010","unstructured":"Mistrangelo M, Pelosi E, Bello M, Castellano I, Cassoni P, Ricardi U, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys. 2010;77(1):73-8. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.020.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"4213_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00259-023-06393-z","volume":"51","author":"SA Mirshahvalad","year":"2023","unstructured":"Mirshahvalad SA, Mesci A, Murad V, Kohan A, Ortega C, Veit-Haibach P, et al. [(18)F]-FDG PET in anal canal cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2023;51(1):258-77. doi: https:\/\/doi.org\/10.1007\/s00259-023-06393-z.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"11","key":"4213_CR24","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","volume":"22","author":"M Jones","year":"2015","unstructured":"Jones M, Hruby G, Solomon M, Rutherford N, Martin J. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2015;22(11):3574-81. doi: https:\/\/doi.org\/10.1245\/s10434-015-4391-9.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"4213_CR25","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/annonc\/mdr599","volume":"23","author":"NJ Bhuva","year":"2012","unstructured":"Bhuva NJ, Glynne-Jones R, Sonoda L, Wong WL, Harrison MK. To PET or not to PET? That is the question. Staging in anal cancer. Ann Oncol. 2012;23(8):2078-82. doi: https:\/\/doi.org\/10.1093\/annonc\/mdr599.","journal-title":"Ann Oncol."},{"issue":"10","key":"4213_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S1470-2045(17)30456-4","volume":"18","author":"H Sekhar","year":"2017","unstructured":"Sekhar H, Zwahlen M, Trelle S, Malcomson L, Kochhar R, Saunders MP, et al. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. Lancet Oncol. 2017;18(10):1348-59. doi: https:\/\/doi.org\/10.1016\/S1470-2045(17)30456-4.","journal-title":"Lancet Oncol."},{"issue":"1080","key":"4213_CR27","doi-asserted-by":"publisher","first-page":"20170370","DOI":"10.1259\/bjr.20170370","volume":"90","author":"A Mahmud","year":"2017","unstructured":"Mahmud A, Poon R, Jonker D. PET imaging in anal canal cancer: a systematic review and meta-analysis. Br J Radiol. 2017;90(1080):20170370. doi: https:\/\/doi.org\/10.1259\/bjr.20170370.","journal-title":"Br J Radiol."},{"issue":"3","key":"4213_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/ije\/dyw276","volume":"46","author":"F Islami","year":"2017","unstructured":"Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46(3):924-38. doi: https:\/\/doi.org\/10.1093\/ije\/dyw276.","journal-title":"Int J Epidemiol."},{"issue":"4","key":"4213_CR29","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S1470-2045(20)30751-8","volume":"22","author":"H Hricak","year":"2021","unstructured":"Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, et al. Medical imaging and nuclear medicine: a Lancet Oncology Commission. Lancet Oncol. 2021;22(4):e136-e72. doi: https:\/\/doi.org\/10.1016\/S1470-2045(20)30751-8.","journal-title":"Lancet Oncol."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04213-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:03:06Z","timestamp":1716253386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04213-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04213-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marc J. Gollub reports a relationship with GlaxoSmithKline that includes: consulting or advisory. Paul B. Romesser reports a relationship with XRAD Therapeutics and EMD Serono that includes: funding grants. The remaining authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of Memorial Sloan Kettering Cancer Center (Date of approval July 12, 2016 \/ No. 16-923).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The need for informed consent was waived by the Institutional Review Board of Memorial Sloan Kettering Cancer Center in view of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}